10-QPeriod: Q2 FY2011

HCA Healthcare, Inc. Quarterly Report for Q2 Ended Jun 30, 2011

Filed August 5, 2011For Securities:HCA

Summary

This 10-Q filing for HCA Healthcare, Inc. (HCA) as of June 29, 2011, highlights significant operational and legal developments. The company's disclosure controls and procedures were deemed effective by its CEO and CFO, with no material changes to internal controls over financial reporting during the period. However, HCA faces ongoing legal and regulatory scrutiny, including a Department of Justice review concerning implantable cardio-defibrillator (ICD) billing across 95 of its hospitals. This review, spanning from October 2003 to the present, could potentially lead to claims under the False Claims Act, with the ultimate impact currently unpredictable. The filing also addresses material risk factors, particularly concerning government health care programs. HCA derives approximately 41% of its revenue from Medicare and Medicaid, making it susceptible to changes in reimbursement policies. The Budget Control Act of 2011 and the Health Reform Law introduce potential reductions in Medicare payments and program integrity initiatives. Furthermore, many states are facing budgetary pressures that could lead to reduced Medicaid reimbursements, as exemplified by an estimated $50 million reduction for HCA hospitals in Florida in late 2011 and early 2012. Changes in these governmental programs, along with commercial payer responses, could materially affect HCA's financial position and results of operations.

Financial Statements
Beta
Revenue$7.25B
Interest Expense$520.00M
Net Income$229.00M
EPS (Basic)$0.44
EPS (Diluted)$0.43
Shares Outstanding (Basic)516.45M
Shares Outstanding (Diluted)538.56M

Key Highlights

  • 1Disclosure controls and procedures were effective as of the period end; no material changes in internal controls over financial reporting.
  • 2HCA is subject to a DOJ review concerning ICD billing practices at 95 hospitals, potentially leading to False Claims Act litigation.
  • 3Approximately 41% of HCA's 2010 revenue was derived from Medicare and Medicaid, making the company vulnerable to changes in these programs.
  • 4The Budget Control Act of 2011 and the Health Reform Law may lead to reductions in Medicare reimbursement rates and increased program integrity efforts.
  • 5State budgetary pressures are likely to result in reduced Medicaid reimbursements, with HCA anticipating an estimated $50 million reduction in Florida.
  • 6HCA entered into an agreement to purchase the remaining ownership interest in HCA-HealthONE LLC for $1.45 billion, expected to close in Q3 2011, funded by its revolving credit facility.

Frequently Asked Questions

The Department of Justice is reviewing ICD billing at 95 HCA hospitals. While HCA cannot predict the effect of this review or any resulting claims under the federal False Claims Act, such claims could have a material adverse effect on the company's results of operations or financial position.

Since Medicare and Medicaid account for a significant portion of HCA's revenue (approximately 41% in 2010), changes in these programs pose a material risk. Legislative actions like the Budget Control Act of 2011 and the Health Reform Law, along with state budget constraints impacting Medicaid, could lead to reduced reimbursement rates and adversely affect HCA's financial performance.

HCA is acquiring the remaining ownership interest in HCA-HealthONE LLC for $1.45 billion. This transaction is expected to close in the third quarter of 2011 and will be funded through HCA's revolving credit facility. This move signifies a consolidation of ownership and is a significant financial event for the company.

Yes, HCA operates in a litigious environment. Beyond the DOJ review, the company is involved in various lawsuits, claims, and legal/regulatory proceedings. A specific case mentioned involves a lawsuit by the Foundation for Seacoast Health regarding restrictions on the Portsmouth Regional Hospital, which has seen mixed rulings on appeal.